Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805630 · ClinicalTrials.gov registry record · NA
Urine Methylation Markers in UTUC
A NA study of Upper Tract Urothelial Cancer, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06805630: Recruiting NA study of Upper Tract Urothelial Cancer, sponsored by Duke University.
NCT06805630 is a NA study of Upper Tract Urothelial Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06805630, a NA study of Upper Tract Urothelial Cancer, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to measure DNA markers in the urine of patients with upper tract urothelial cancer (UTUC) before surgery and during follow-up visits. Identifying these DNA markers could improve diagnosis before surgery, help assess risk, and predict early recurrence of the cancer. Urine samples will be de-identified and sent to Pangea Laboratory LLC for analysis. The results of this test will be compared to the traditional tests in upper tract urothelial cancer, such as cells in the urine and tissue biopsy.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bladder CARE™
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-05-07 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06805630 shows while recruiting
NCT06805630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Upper Tract Urothelial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Bladder CARE™ is the first listed.
NCT06805630 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06805630 about?
NCT06805630 is a clinical study titled "Urine Methylation Markers in UTUC". This is a research study to measure DNA markers in the urine of patients with upper tract urothelial cancer (UTUC) before surgery and during follow-up visits. Identifying these DNA markers could improve diagnosis before surgery, help assess risk, and predict early recurrence of the cancer. Urine sam...
What is the current status of trial NCT06805630?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-05-07. Estimated completion is 2026-06.
What conditions does trial NCT06805630 study?
This clinical trial studies the following conditions: Upper Tract Urothelial Cancer.
What interventions are being tested in trial NCT06805630?
The interventions under investigation include: Bladder CARE™ (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06805630?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06805630 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06805630's enrollment target sits among peer trials
50 1280th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI